Amgen eyes potential acquisitions

03 Mar 2003
News

Executive Summary

Amgen's consolidation of Immunex gives the company confidence that it could pursue other large agreements, CEO Sharer said Feb. 25, but "that doesn't mean we're just going to [do] it for the heck of it." While "acquisitions are something that we don't expect," Sharer says, "obviously, given that prices are much lower right now, we're looking harder." The CEO outlined Amgen's criteria for a takeover prospect, which include an ability to drive top-line growth and a fit with Amgen's culture...

Existing Subscriber? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS041336

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS041336

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Amgen eyes potential acquisitions

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Amgen eyes potential acquisitions

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert